Found: 2
Select item for more details and to access through your institution.
307 The study design of a trial of dupilumab in adult patients with bullous pemphigoid (BP): LIBERTY-BP ADEPT.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii4, doi. 10.1093/bjd/ljac140.007
- By:
- Publication type:
- Article
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 4, p. 567, doi. 10.1007/s40257-020-00527-x
- By:
- Publication type:
- Article